{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:09:21Z","timestamp":1785863361680,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1097\/01.gme.0000247016.41007.c9","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T04:58:58Z","timestamp":1159333138000},"page":"917-925","source":"Crossref","is-referenced-by-count":48,"title":["Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women"],"prefix":"10.1097","volume":"13","author":[{"given":"Stephen G.","family":"Swanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Drosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans A.","family":"Helmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210227","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1002\/j.1552-4604.1995.tb04141.x","article-title":"Estrogen therapy for postmenopausal symptoms and prevention of osteoporosis.","volume":"35","author":"Sagraves","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"R2-11-20210227","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0095-4543(22)00096-3","article-title":"Menopause.","volume":"24","author":"Thacker","year":"1997","journal-title":"Prim Care"},{"key":"R3-11-20210227","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.1980.03310130021021","article-title":"Oral medroxyprogesterone in the treatment of postmenopausal symptoms.","volume":"244","author":"Schiff","year":"1980","journal-title":"JAMA"},{"key":"R4-11-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women: systemic review of randomized trials.","volume":"87","author":"Modelska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"R5-11-20210227","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.maturitas.2004.02.012","article-title":"Tissue-selectivity: the mechanism of action of tibolone.","volume":"48","author":"Kloosterboer","year":"2004","journal-title":"Maturitas"},{"key":"R6-11-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators.","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr Rev"},{"key":"R7-11-20210227","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00042192-200207000-00005","article-title":"Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys.","volume":"9","author":"Cline","year":"2002","journal-title":"Menopause"},{"key":"R8-11-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0960-0760(93)90003-F","article-title":"Human endometrial 3-hydroxysteroid dehydrogenase\/isomerase can locally reduce intrinsic estrogenic\/progestagenic activity ratios of steroidal drugs.","volume":"45","author":"Tang","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R9-11-20210227","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.2001.16.9.1651","article-title":"Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.","volume":"16","author":"Ederveen","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R10-11-20210227","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0039-128X(02)00112-5","article-title":"Receptor profiling and endocrine interactions of tibolone.","volume":"68","author":"de Gooyer","year":"2003","journal-title":"Steroids"},{"key":"R11-11-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(01)00966-9","article-title":"Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats.","volume":"419","author":"Berendsen","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R12-11-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0303-7207(01)00606-2","article-title":"Tibolone: a compound with tissue specific inhibitory effects on sulfatase.","volume":"183","author":"de Gooyer","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"R13-11-20210227","first-page":"131","article-title":"Guidance for clinical evaluation of combination estrogen\/progestin-containing drug products used for hormone replacement therapy of postmenopausal women.","volume":"2","year":"1995","journal-title":"Menopause"},{"key":"R14-11-20210227","first-page":"115","article-title":"The Bethesda system for reporting cervical\/vaginal cytologic diagnoses.","volume":"372","year":"1993","journal-title":"Acta Cytol"},{"key":"R16-11-20210227","first-page":"69","article-title":"The use of a new steroid (Org OD 14) in the climacteric syndrome.","volume":"6","author":"Cittadini","year":"1982","journal-title":"Reproduccion"},{"key":"R19-11-20210227","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-5122(88)90095-3","article-title":"Treatment of climacteric complaints with Org OD14: a comparative study with oestradiol valerate and placebo.","volume":"9","author":"Crona","year":"1988","journal-title":"Maturitas"},{"key":"R20-11-20210227","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0378-5122(86)90040-X","article-title":"Benefits and risks of different hormonal therapies in postmenopausal women.","volume":"8","author":"Volpe","year":"1986","journal-title":"Maturitas"},{"key":"R21-11-20210227","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.1998.tb10237.x","article-title":"A double-blind randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.","volume":"105","author":"Hammar","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R22-11-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(94)00889-F","article-title":"A comparative study of two hormone replacement therapy regimes on safety and efficacy variables.","volume":"21","author":"Siseles","year":"1995","journal-title":"Maturitas"},{"key":"R23-11-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5122(00)00154-7","article-title":"Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17-estradiol for hormone replacement therapy in women with surgical menopause.","volume":"37","author":"Mendoza","year":"2000","journal-title":"Maturitas"},{"key":"R24-11-20210227","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.maturitas.2004.06.001","article-title":"Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.","volume":"50","author":"Landgren","year":"2005","journal-title":"Maturitas"},{"key":"R25-11-20210227","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Dose-response analysis of effects of tibolone on climacteric symptoms.","volume":"109","author":"Landgren","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"R26-11-20210227","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-5122(94)90050-7","article-title":"A study of the effect of tibolone on the vagina in postmenopausal women.","volume":"18","author":"Rymer","year":"1994","journal-title":"Maturitas"},{"key":"R27-11-20210227","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/cmt.4.1.28.41","article-title":"The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.","volume":"4","author":"Laan","year":"2001","journal-title":"Climacteric"},{"key":"R28-11-20210227","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-5122(84)90023-9","article-title":"Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomised women.","volume":"5","author":"Punnonen","year":"1984","journal-title":"Maturitas"},{"key":"R29-11-20210227","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-0528.1999.tb08436.x","article-title":"Long-term effects of tibolone on the genital tract in postmenopausal women.","volume":"106","author":"Morris","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl 1","key":"R30-11-20210227","first-page":"S50","article-title":"Effects on the lower genital tract of tibolone use for 8 years in postmenopausal women.","volume":"35","author":"Morris","year":"2000","journal-title":"Maturitas"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200613060-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:07:55Z","timestamp":1785859675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200613060-00011"}},"subtitle":["a multicenter, randomized, double-blind, placebo-controlled study"],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gme.0000247016.41007.c9","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}